Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Yinuo Animal Pharmaceutical is a comprehensive veterinary medicine enterprise based in Shijiazhuang, China, focusing on the research, production, and distribution of animal health products. The company operates large-scale manufacturing facilities that are fully compliant with Good Manufacturing Practice (GMP) standards, producing a diverse range of dosage forms including sterile injections, powders, and oral liquids. Their extensive product portfolio targets livestock, poultry, and aquatic animals, addressing critical needs in infectious disease control, parasite management, and nutritional support. Yinuo Animal Pharmaceutical emphasizes quality control and technological innovation to maintain its position in the competitive domestic and international veterinary markets. The company's offerings include well-known agents such as ivermectin, oxytetracycline, and various traditional Chinese veterinary medicines. Through its integrated business model, it provides essential healthcare solutions to the global agricultural and animal husbandry industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Yinuo Animal Pharmaceutical.